Skip to content

Exercise training and type 2 diabetes

The effect of aerobic and resistance and combined exercise on the expression of mir-15a, muscular strength and endurance in women with type 2 diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240721062487N2
Enrollment
80
Registered
2025-02-27
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus without complications

Interventions

Intervention 1: Control group: Having a normal life routine within 8 weeks. Intervention 2: Intervention group: Performing aerobic exercise. Intervention 3: Intervention group: Performing endurance ex

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Gender: Female Aged between 30-60 years Not participating in regular physical activity Not using drugs Not using insulin injections Normal examination of the diabetic foot Not chest pain or heaviness or history of hospitalization for heart disease Not history of retinal bleeding and Avastin injection( No history of Proliferative retinopathy) No other underlying disease

Exclusion criteria

Exclusion criteria: Voluntary withdrawal of participants from continuing the study Having a specific illness that prevents physical activity Occurrence of physical injury Absence of more than three session in sports interventions Pregnancy

Design outcomes

Primary

MeasureTime frame
MiRNA-15a, FBS, HDL, LDL, CREATININE, Muscle endurance and strength. Timepoint: 48 hours before intervention, after intervention for 2 months. Method of measurement: Blood sampling, Dynamometer, Fitness tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Ghasemipour

The University of Isfahan

Sghasemipr@spr.ui.ac.ir+98 31 3747 4393

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026